PTPRC and neoplasm: Intriguingly, a triple combination of 5-AZA, HDACi and α-PD-1 increased the infiltration of CD45+ immune cells, NK cells and active CD8+ T cells, while reducing tumor burden and extending survival through type I IFN signaling, while triple combination provided the best anti-tumor performance in the murine models [287].